A subset of senile dementia with high incidence of the apolipoprotein E ε2 allele

Annals of Neurology

Volumn 41, Issue 5, 1997, Pages 693-695

  Ikeda, Kenji ^a   Akiyama, Haruhiko ^a   Arai, Tetsuaki ^a   Sahara, Naruhiko ^a   Mori, Hiroshi ^a   Usami, Mihoko ^a   Sakata, Masuhiro ^b   Mizutani, Toshio ^b   Wakabayashi, Koichi ^c   Takahashi, Hitoshi ^c  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^c NIIGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4;

AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE DURATION; GENOTYPE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; NEUROPATHOLOGY; PRIORITY JOURNAL; SENILE DEMENTIA; SENILE PLAQUE;

AGED; AGED, 80 AND OVER; APOLIPOPROTEIN E2; APOLIPOPROTEINS E; DEMENTIA; GENE FREQUENCY; GENOTYPE; GLIOSIS; HIPPOCAMPUS; HUMANS; NEUROFIBRILLARY TANGLES; RETROSPECTIVE STUDIES;

EID: 0030972858     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410410522     Document Type: Article

References (22)

1. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familiat Alzheimet's disease. Proc Natl Acad Sci USA 1993;90:1977-1981
2. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele ε4 with late-onset familiar and sporadic Alzheimer's disease. Neurology 1993;43:1467-1472
3. Chartier-Harlin MC, Parfitt M, Legrain S, et al. Apolipoprotein E, E4 allele as a major risk factor for sporadic early and lateonset form of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Hum Mol Genet 1994;3:569-574
4. Roses AD. Apolipoprotein E affects the rate of Alzheimer disease expression: β-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease. J Neuropathol Exp Neurol 1994;53:429-437
5. Strittmatter WJ, Weisgraber KH, Huang DY, et al. Binding of human apolipoprotein E to synthetic amyloid β peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci USA 1993;90:8098-8102
6. Sanan DA, Weisgraber KH, Russell SJ, et al. Apolipoprotein E associates with β amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform ApoE4 associates more efficiently than ApoE3. J Clin Invest 1994;94:860-869
7. Ma J, Yee A, Brewer BH Jr, et al. Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments. Nature 1994;372:92-94
8. Castano EM, Prelli F, Wisniewski T, et al. Fibrillogenesis in Alzheimer's disease of amyloid β peptides and apolipoprotein E. Biochem J 1995;306:599-604
9. Gomez-Isla T, West HL, Rebeck GW, et al. Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease. Ann Neurol 1995;39:62-70
10. Corder EH, Saunder AM, Risch NJ, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet 1994;7:180-184
11. Ulrich J, Spillantini MG, Goedert M, et al. Abundant neurofibrillary tangles without senile plaques in a subset of patients with senile dementia. Neurodegeneration 1992;1:257-264
12. Bancher C, Jellinger KA. Neurofibrillary tangle predominant form of senile dementia of Alzheimer type; a rare subtype in very old subjects. Acta Neuropathol (Berl) 1994;88:565-570
13. Mizutani T. Neuropathological diagnosis of senile dementia of Alzheimer type (SDAT): proposal of diagnostic criteria and report of Japanese research meeting on neuropathological diagnosis of SDAT. Neuropathology 1994;14:91-103
14. Yamada M, Itoh Y, Otomo E, et al. Dementia of the Alzheimer type and related dementias in the aged: DAT subgroups and senile dementia of the neurofibrillary type. Neuropathology 1996;16:89-98
15. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol (Berl) 1991;82:239-259
16. Khachaturian ZS. Diagnosis of Alzheimer's disease. Arch Neurol 1985;42:1097-1105
17. Yamada M, Itoh Y, Suematsu N, et al. Apolipoprotein E genotype in elderly nondemented subjects without senile changes in the brain. Ann Neurol 1996;40:243-245
18. West HL, Rebeck W, Hyman BT. Frequency of the apolipoprotein E ε2 allele is diminished in sporadic Alzheimer disease. Neurosci Lett 1994;175:46-48
19. Talbot C, Lendon C, Craddock N, et al. Protection against Alzheimer's disease with apoE ε2. Lancet 1994;343:1432-1433
20. Rebeck GW, Perls TT, West HL, et al. Reduced apolipoprotein ε4 allele frequency in the oldest old Alzheimer's patients and cognitively normal individuals. Neurology 1994;44:1513-1516
21. Schächter FS, Faure-Delanef L, Guenot F, et al. Genetic associations with human longevity at the APOE and ACE loci. Nat Genet 1994;6:29-32
22. Asada T, Yamagata Z, Kinoshita T, Asaka A. Apolipoprotein E allele of demented and non-demented centenarians: complete survey of centenarians in Yamanashi prefecture. Jpn J Geriatr 1995;32:134-135Brief Communication: Bornebroek et al: HCHWA-D Lesions and APOE